StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) Reiterated at Neutral by Cantor Fitzgerald on Negative SV Data
June 23, 2026 7:24 AM
Cantor Fitzgerald analyst Carter Gould reiterated a Neutral rating and $27.00 price target on Pfizer (NYSE: PFE).The analyst commented, "Pfizer ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
